Literature DB >> 24444388

NOD1 and NOD2 expression and function in very preterm infant mononuclear cells.

Caitlyn Granland1, Tobias Strunk, Julie Hibbert, Amy Prosser, Karen Simmer, David Burgner, Peter Richmond, Andrew J Currie.   

Abstract

AIM: To evaluate mononuclear cell expression and function of the cytosolic nucleotide-binding oligomerization domain-containing receptors, NOD1 and NOD2, in very preterm and full-term infants.
METHODS: NOD1 and NOD2 gene and protein expression in very preterm infants, term infants and healthy adult, cord and peripheral blood mononuclear cells (C/PBMC) were quantified using qPCR and flow cytometry. Cytokine responses of purified infant and adult monocytes to NOD1- and NOD2-specific agonists were assessed using a multiplex immunoassay (Bioplex).
RESULTS: NOD1 and NOD2 were expressed by a range of infant and adult mononuclear cell types, including T- and B cells, with highest expression in classical (CD14(++) CD16(-) ) and intermediate (CD14(++) CD16(+) ) monocytes. NOD1 and NOD2 expression levels by monocytes from very preterm infant were similar to those in term infants or adults. Monocyte production of TNFα, IL-6 and IL-1β induced by activation of NOD1 and NOD2 was similar between very preterm infants, term infants and adults.
CONCLUSION: Monocyte expression and function of NOD1 and NOD2 in very preterm infants are intact and comparable/equivalent to term infants and adults. Functional deficiencies in monocyte NOD signalling pathways are unlikely to contribute to the increased susceptibility to bacterial sepsis in preterm infants. ©2014 Foundation Acta Paediatrica. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Innate immunity; Monocyte; NOD1; NOD2; Preterm infant

Mesh:

Substances:

Year:  2014        PMID: 24444388     DOI: 10.1111/apa.12559

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  5 in total

1.  Activation of Nod1 Signaling Induces Fetal Growth Restriction and Death through Fetal and Maternal Vasculopathy.

Authors:  Hirosuke Inoue; Hisanori Nishio; Hidetoshi Takada; Yasunari Sakai; Etsuro Nanishi; Masayuki Ochiai; Mitsuho Onimaru; Si Jing Chen; Toshiro Matsui; Toshiro Hara
Journal:  J Immunol       Date:  2016-02-15       Impact factor: 5.422

Review 2.  Ontogeny of early life immunity.

Authors:  David J Dowling; Ofer Levy
Journal:  Trends Immunol       Date:  2014-05-28       Impact factor: 16.687

3.  Development and maturation of the immune system in preterm neonates: results from a whole genome expression study.

Authors:  Magdalena Zasada; Przemko Kwinta; Wojciech Durlak; Mirosław Bik-Multanowski; Anna Madetko-Talowska; Jacek Józef Pietrzyk
Journal:  Biomed Res Int       Date:  2014-05-28       Impact factor: 3.411

Review 4.  Beyond sepsis: Staphylococcus epidermidis is an underestimated but significant contributor to neonatal morbidity.

Authors:  Ying Dong; Christian P Speer; Kirsten Glaser
Journal:  Virulence       Date:  2018-01-01       Impact factor: 5.882

5.  Expression and in vitro assessment of tumorigenicity for NOD1 and NOD2 receptors in breast cancer cell lines.

Authors:  Fernando J Velloso; Mari Cleide Sogayar; Ricardo G Correa
Journal:  BMC Res Notes       Date:  2018-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.